Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood–brain barrier
- 5 September 2011
- journal article
- Published by Elsevier in Neuroscience
- Vol. 190, 37-42
- https://doi.org/10.1016/j.neuroscience.2011.05.076
Abstract
No abstract availableKeywords
Funding Information
- IOP Genomics Senter (IGE05005)
- Center of Medical Systems Biology (CMSB2)
- Center for Translational Molecular Medicine
- Netherlands Consortium for Systems Biology
This publication has 22 references indexed in Scilit:
- 2B-Trans™ Technology: Targeted Drug Delivery Across the Blood-Brain BarrierPublished by Springer Nature ,2008
- The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cellsJournal of Neurochemistry, 2005
- Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulinsVaccine, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Establishment and functional characterization of an in vitro model of the blood–brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytesEuropean Journal of Pharmaceutical Sciences, 2001
- HPLC-Based Method for Estimating the Temperature Dependence of n-Octanol−Water Partition CoefficientsJournal of Chemical & Engineering Data, 2000
- Determination of active single chain antibody concentrations in crude periplasmic fractionsJournal of Immunological Methods, 1996
- An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde”Clinical Anatomy, 1995
- Naturally occurring antibodies devoid of light chainsNature, 1993